تفاصيل الوثيقة

نوع الوثيقة : مقال في مجلة دورية 
عنوان الوثيقة :
Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression
Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression
 
لغة الوثيقة : الانجليزية 
المستخلص : Meningiomas are the most common primary brain tumors bearing in a minority of cases an aggressive phenotype. Although meningiomas are stratified according to their histology and clinical behavior, the underlying molecular genetics predicting aggressiveness are not thoroughly understood. We performed whole transcript expression profiling in 10 grade I and four grade II meningiomas, three of which invaded the brain. Microarray expression analysis identified deleted in colorectal cancer (DCC) as a differentially expressed gene (DEG) enabling us to cluster meningiomas into DCC low expression (3 grade I and 3 grade II tumors), DCC medium expression (2 grade I and 1 grade II tumors), and DCC high expression (5 grade I tumors) groups. Comparison between the DCC low expression and DCC high expression groups resulted in 416 DEGs (p-value < 0.05; fold change > 2). The most significantly downregulated genes in the DCC low expression group comprised DCC, phosphodiesterase 1C (PDE1C), calmodulin-dependent 70kDa olfactomedin 2 (OLFM2), glutathione S-transferase mu 5 (GSTM5), phosphotyrosine interaction domain containing 1 (PID1), sema domain, transmembrane domain (TM) and cytoplasmic domain, (semaphorin) 6D (SEMA6D), and indolethylamine N-methyltransferase (INMT). The most significantly upregulated genes comprised chromosome 5 open reading frame 63 (C5orf63), homeodomain interacting protein kinase 2 (HIPK2), and basic helix-loop-helix family, member e40 (BHLHE40). Biofunctional analysis identified as predicted top upstream regulators beta-estradiol, TGFB1, Tgf beta complex, LY294002, and dexamethasone and as predicted top regulator effectors NFkB, PIK3R1, and CREBBP. The microarray expression data served also for a comparison between meningiomas from female and male patients and for a comparison between brain invasive and non-invasive meningiomas resulting in a number of significant DEGs and related biofunctions. In conclusion, based on its expression levels, DCC may constitute a valid biomarker to identify those benign meningiomas at risk for progression. 
ردمد : 1932-6203 
اسم الدورية : PLoS ONE 
المجلد : 11 
العدد : 4 
سنة النشر : 1437 هـ
2016 م
 
نوع المقالة : مقالة علمية 
تاريخ الاضافة على الموقع : Wednesday, October 5, 2016 

الباحثون

اسم الباحث (عربي)اسم الباحث (انجليزي)نوع الباحثالمرتبة العلميةالبريد الالكتروني
Hans-Juergen SchultenSchulten, Hans-Juergen باحث رئيسيدكتوراه 
Deema HusseinHussein, Deema باحث  
Fatima Al-AdwaniAl-Adwani, Fatima باحث  
Sajjad KarimKarim, Sajjad باحثدكتوراه 
Jaudah Al-MaghrabiAl-Maghrabi, Jaudah باحثدكتوراه 
Mona Al-SharifAl-Sharif, Mona باحث  
Awatif JamalJamal, Awatif باحث  
Fahad Al-GhamdIAl-GhamdI, Fahad باحث  
Saleh BaeesaBaeesa, Saleh باحث  
Mohammed BangashBangash, Mohammed باحث  
Adeel ChaudharyChaudhary, Adeel باحثدكتوراه 
Mohammed Al-QahtaniAl-Qahtani, Mohammed باحث  

الملفات

اسم الملفالنوعالوصف
 39430.pdf pdf 

الرجوع إلى صفحة الأبحاث